Submitted by Anonymous (not verified) on 10 November 2025 - 15:55
Human medicines European public assessment report (EPAR): Nemluvio, nemolizumab, Date of authorisation: 12/02/2025, Revision: 3, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Nemluvio, nemolizumab, Date of authorisation: 12/02/2025, Revision: 3, Status: Authorised